This brand name is authorized in Austria, Brazil, Germany, Italy
The drug RIOPAN contains one active pharmaceutical ingredient (API):
|
1
Magaldrate
UNII 0MFM55849I - MAGALDRATE ANHYDROUS
|
|
Magaldrate is a common antacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02AD02 | Magaldrate | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AD Combinations and complexes of aluminium, calcium and magnesium compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501103004130418 |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00749293, 00749301, 00749318, 01139645, 01139668, 07110186, 08592922, 08592939, 08592945 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 027103023, 027103035, 027103047 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
